|
| |
Takeda Pharmaceutical Company Limited1781 Founding Over two centuries ago in 1781, 32-year-old Chobei Takeda I started a business selling traditional Japanese and Chinese medicines in Doshomachi, Osaka, the center of the medicine trade in Japan. His small shop bought medicines from wholesalers, then divided them into smaller batches and sold them to local medicine merchants and doctors. This was the beginning of the present-day Takeda Chemical Industries, Ltd.
| Contact Details: |
| 1-1, Doshomachi 4-chome |
| Chuo-ku |
| Osaka |
| 540-8645 |
| Japan |
| Tel: | 81-6-6204-2111 |
| Fax: | 81-6-6204-2880 |
| Email: | |
| WWW: | www.takeda.co.jp/
|
| |
Recent Publications by Takeda Pharmaceutical Company Limited: |  |
Synthesis and biological evaluation of the metabolites of 2-(1-{3-[(6-chloronaphthalen-2-yl)sulfonyl]propanoyl}piperidin-4-yl)-5-met hyl-1,2-dihydro-3H-imidazo[1,5-c]imidazol-3-one.
We have recently discovered imidazo[1,5-c]imidazol-3-one derivative 1 as a... | 29th October, 2009
| Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd,
| Bioorg Med Chem. 2009 Dec 1;17(23):7993-8002. Epub 2009 Oct 14.
DOI Direct Link |
Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
Drug candidates under development by industry frequently show... | 2nd October, 2009
| Development Research Center, Pharmaceutical Research Division, Takeda
| Toxicol Mech Methods. 2009 Oct;19(8):477-85.
DOI Direct Link |
In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
It is known that many genotoxic chemicals require oxidative metabolism to... | 29th September, 2009
| Development Research Center, Pharmaceutical Research Division, Takeda
| Mutat Res. 2009 Jun-Jul;677(1-2):1-7. Epub 2009 Jun 6.
DOI Direct Link |
2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazol e derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.
Glycogen synthase kinase 3beta (GSK-3beta) inhibition is expected to be a... | 25th September, 2009
| Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.,
| J Med Chem. 2009 Oct 22;52(20):6270-86.
DOI Direct Link |
[A novel therapeutic drug: ramelteon]
Current treatment of insomnia with hypnotics, GABA(A) receptor modulators,... | 23rd September, 2009
| Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited.
| Nippon Rinsho. 2009 Aug;67(8):1595-600.
|
→View more Takeda Pharmaceutical Company Limited research publications. |
Press Releases on Takeda Pharmaceutical Company Limited:
|
 |
| Reportlinker Adds Asia Pacific Pharma Sector Analysis |
12th November, 2009 |
Reportlinker |
NEW YORK, Nov. 12 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Asia Pacific Pharma Sector Analysis
http://www.reportlinker.com/p0163724
|
| Reportlinker Adds US World Nutraceutical Ingredients Industry |
10th November, 2009 |
Reportlinker |
NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
US World Nutraceutical Ingredients Industry
http://www.reportlinker.com
|
| Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results |
6th November, 2009 |
Ardea Biosciences, Inc. |
-- Ardea also presented at the ACR/ARHP meeting data from preclinical
drug-drug interaction studies demonstrating RDEA594's potential to be
used in combination with
|
| Takeda Establishes Takeda Pharmaceuticals Mexico, S.A. de C.V. Expanding Presence in North America |
3rd November, 2009 |
Takeda Pharmaceuticals North America, Inc. |
DEERFIELD, Ill., Nov. 3 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc., today announced the incorporation of Takeda Pharmaceuticals Mexico, S.A. de C.V. This expansion strengthens the
|
| New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD |
26th October, 2009 |
Takeda Pharmaceuticals North America, Inc. |
SAN DIEGO, Oct. 26 /PRNewswire/ -- New data being presented at the American College of Gastroenterology (ACG) 2009 Annual Scientific Meeting in San Diego showed that treatment with KAPIDEX(TM)
|
BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 13 individuals from Takeda Pharmaceutical Company Limited using this service.  Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 562 times since April 2007, the link to the organisation's website has been followed 59 times Recent Search Terms used to find this page: TAKEDA PHARMACEUTICAL COMPANY LTD. address | takeda, otsuka drug companies trade | takeda pharmaceutical japan email | biowa announces second jp licence of potelligent | azmi takeda | Takeda Pharmaceutical india address | takeda pharmaceutical company address | Takeda Pharmaceuticals Tak-599 | takeda pharmaceutical diabetes ph.d. | voglibose metformin dissolution methods | . Search for more companies in Chuo-ku Search for more companies in Osaka This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Takeda Pharmaceutical Company Limited |
